Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 256 | $189,929,373 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 03 May 2023 | Sale | 1,800 | 350.53 | 630,954 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 03 May 2023 | Sale | 2,008 | 349.22 | 701,234 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 02 May 2023 | Sale | 300 | 353.18 | 105,954 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 02 May 2023 | Sale | 1,505 | 350.48 | 527,472 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 02 May 2023 | Sale | 4,645 | 349.48 | 1,623,335 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 63 | 351.2 | 22,126 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 163 | 349.82 | 57,021 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 120 | 348.16 | 41,779 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 172 | 346.69 | 59,631 | D |
03 May 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2023 | Sale | 62 | 345.93 | 21,448 | D |
01 May 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 27 Apr 2023 | Sale | 38 | 340.19 | 12,927 | D |
01 May 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 27 Apr 2023 | Sale | 1,668 | 339.43 | 566,169 | D |
01 May 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 27 Apr 2023 | Sale | 1,611 | 338.69 | 545,630 | D |
14 Apr 2023 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 12 Apr 2023 | Sale | 2,625 | 327.43 | 859,504 | D |
14 Apr 2023 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 12 Apr 2023 | Sale | 4,068 | 326.45 | 1,327,999 | D |
14 Apr 2023 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 12 Apr 2023 | Sale | 874 | 325.7 | 284,662 | D |
14 Apr 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 12 Apr 2023 | Sale | 8,026 | 327.48 | 2,628,354 | D |
14 Apr 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 12 Apr 2023 | Sale | 10,357 | 326.46 | 3,381,146 | D |
14 Apr 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 12 Apr 2023 | Sale | 2,917 | 325.65 | 949,921 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 31 | 318.68 | 9,879 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 96 | 317.65 | 30,494 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 90 | 316.76 | 28,508 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 94 | 315.66 | 29,672 | D |
06 Apr 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 Apr 2023 | Sale | 211 | 314.22 | 66,300 | D |
28 Mar 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 24 Mar 2023 | Sale | 1,768 | 305.38 | 539,912 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 16 | 301.13 | 4,818 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 240 | 299.58 | 71,899 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 360 | 298.09 | 107,312 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 240 | 296.3 | 71,112 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 784 | 295.43 | 231,617 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 360 | 294.52 | 106,027 | D |
20 Mar 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 Mar 2023 | Sale | 264 | 301.07 | 79,482 | D |
20 Mar 2023 16:26 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 Mar 2023 | Sale | 2,482 | 300.54 | 745,940 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 62 | 296.77 | 18,400 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 292 | 295.89 | 86,400 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 715 | 294.52 | 210,582 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 1,153 | 293.35 | 338,233 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 420 | 292.41 | 122,812 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 24 | 288.31 | 6,919 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 102 | 294.94 | 30,084 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 27 | 293.61 | 7,927 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 185 | 292.68 | 54,146 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 541 | 291.47 | 157,685 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 30 | 289.44 | 8,683 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 327 | 288.91 | 94,474 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 515 | 287.83 | 148,232 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 361 | 286.64 | 103,477 | D |
28 Feb 2023 17:11 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 27 Feb 2023 | Sale | 20 | 289.29 | 5,786 | D |
28 Feb 2023 17:11 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 27 Feb 2023 | Sale | 51 | 288.33 | 14,705 | D |
28 Feb 2023 17:11 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 27 Feb 2023 | Sale | 283 | 287.2 | 81,278 | D |
28 Feb 2023 16:47 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 27 Feb 2023 | Sale | 800 | 288.92 | 231,136 | D |
28 Feb 2023 16:47 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 27 Feb 2023 | Sale | 400 | 287.59 | 115,036 | D |
28 Feb 2023 16:47 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 27 Feb 2023 | Sale | 3,834 | 287.16 | 1,100,971 | D |
28 Feb 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 27 Feb 2023 | Sale | 42 | 289.63 | 12,164 | D |
28 Feb 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 27 Feb 2023 | Sale | 183 | 288.68 | 52,828 | D |
28 Feb 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 27 Feb 2023 | Sale | 982 | 287.25 | 282,080 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 302 | 289.6 | 87,459 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 300 | 288.74 | 86,622 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 3,636 | 287.23 | 1,044,368 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 200 | 296.31 | 59,262 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 394 | 295.38 | 116,380 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 1,378 | 294.29 | 405,532 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 300 | 292.86 | 87,858 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 129 | 291.84 | 37,647 | D |
22 Feb 2023 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2023 | Sale | 124 | 294.77 | 36,551 | D |
22 Feb 2023 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2023 | Sale | 207 | 293.83 | 60,823 | D |
22 Feb 2023 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2023 | Sale | 145 | 292.85 | 42,463 | D |
22 Feb 2023 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2023 | Sale | 4 | 291.01 | 1,164 | D |
22 Feb 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2023 | Sale | 736 | 294.58 | 216,811 | D |
22 Feb 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2023 | Sale | 1,100 | 293.74 | 323,114 | D |
22 Feb 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2023 | Sale | 545 | 292.77 | 159,560 | D |
22 Feb 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2023 | Sale | 21 | 291.01 | 6,111 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 900 | 294.73 | 265,257 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 1,843 | 294.03 | 541,897 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 1,223 | 292.76 | 358,045 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 36 | 291.01 | 10,476 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 51 | 300.58 | 15,330 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 135 | 299.6 | 40,446 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 43 | 297.98 | 12,813 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 20 | 296.48 | 5,930 | D |
16 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 14 Feb 2023 | Sale | 71 | 295.89 | 21,008 | D |
16 Feb 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 14 Feb 2023 | Sale | 279 | 301.11 | 84,010 | D |
16 Feb 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 14 Feb 2023 | Sale | 1,902 | 300.29 | 571,152 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 400 | 300.89 | 120,356 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 1,734 | 300.09 | 520,356 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 2,003 | 299.13 | 599,157 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 560 | 298.14 | 166,958 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 901 | 296.85 | 267,462 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 800 | 295.84 | 236,672 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 308 | 301.02 | 92,714 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 1,888 | 300.11 | 566,608 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 2,165 | 299.08 | 647,508 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 395 | 297.97 | 117,698 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 842 | 296.85 | 249,948 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 800 | 295.79 | 236,632 | D |
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 11 | 300.79 | 3,309 | D |
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 64 | 299.88 | 19,192 | D |
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 120 | 298.98 | 35,878 | D |
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 78 | 298.11 | 23,253 | D |
14 Feb 2023 17:12 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 13 Feb 2023 | Sale | 2 | 295.84 | 592 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)